Systemic treatment with corticosteroids in psoriasis--health care provision far beyond the S3-guidelines.
Beteiligte Einrichtungen
Abstract
The basis of induction therapy for psoriasis in Germany is the S3-guideline which for moderate to severe psoriasis recommends the systemic agents fumaric acid esters, methotrexate, cyclosporine and the biologicals infliximab, etanercept, adalimumab and ustekinumab. Systemic glucocorticosteroids (GCS) are not proposed.
Bibliografische Daten
| Originalsprache | Englisch |
|---|---|
| Aufsatznummer | 10 |
| ISSN | 1610-0379 |
| Status | Veröffentlicht - 2011 |
| pubmed | 21627773 |
|---|
